Caption Management’s Zimmer Biomet ZBH Stock Holding History

Caption Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,500	Closed	-$2.38M	–	2120
2024 Q4	$2.38M	Buy	+22,500	New	+$2.41M	0.02%	632
2024 Q2	–	Sell	-2,200	Closed	-$290K	–	1561
2024 Q1	$290K	Sell	2,200 -10,800	-83%	-$1.35M	﹤0.01%	957
2023 Q4	$1.58M	Buy	+13,000	New	+$1.45M	0.02%	678
2021 Q4	–	Sell	-12,772	Closed	-$1.81M	–	1995
2021 Q3	$1.81M	Buy	+12,772	New	+$1.88M	0.02%	802
2020 Q3	–	Sell	-8,927	Closed	-$1.03M	–	1301
2020 Q2	$1.03M	Buy	+8,927	New	+$1.03M	0.03%	524

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caption Management's ZBH Position: Q1 2025 in Review

Caption Management sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 22,500 shares — an estimated $2.38M sold.

Caption Management first reported a position in ZBH in Q2 2020 and held it in 5 quarters. The position peaked at $2.38M in Q4 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

Caption Management reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
Caption Management sold 22,500 Zimmer Biomet shares in Q1 2025, an estimated $2.38M.
Caption Management first reported a position in Zimmer Biomet in Q2 2020 and held it in 5 quarters.
Caption Management's Zimmer Biomet position peaked at $2.38M in Q4 2024.
1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.